EPISODES

three men sitting in a podcast studio

Building a Culture of Research Excellence: Insights from Dr. Antonio Bianco & Dr. Alan Landay

MP3

More Information

Dr. Antonio Bianco, MD, PhD
Dr. Antonio Bianco joined UTMB as Vice President and Vice Provost of Research and Chief Research Officer in September 2024. A distinguished physician-scientist, Dr. Bianco has made significant contributions to thyroid disease research and is committed to advancing education and mentorship. He earned his MD from the Santa Casa Medical School and his PhD in human physiology from the University of São Paulo. His career includes roles as Chief of the Thyroid Section at Brigham and Women’s Hospital, Director of the Thyroid Study Unit at the University of Chicago, and Professor in the Department of Medicine. His groundbreaking research on thyroid hormone metabolism has had a lasting impact on clinical treatments for hypothyroidism. Dr. Bianco has received numerous awards and served as the president of the American Thyroid Association. At UTMB, he continues to lead innovative research in endocrinology and is committed to propelling the institution’s research enterprise to new heights.

Dr. Alan Landay, PhD
Dr. Alan Landay, Vice President of Team Science at UTMB, brings over 42 years of research expertise, particularly in HIV and aging-related studies. Before joining UTMB, Dr. Landay served as Vice Chair of Research and Division Chief of Translational and Precision Medicine at Rush University. He has played a pivotal role in HIV research, including the development of the first FDA-approved HIV antibody test and important studies on immune activation in aging populations. Dr. Landay has led studies within the Advancing Clinical Therapeutics Network and has focused on the human microbiome and metabolome in recent years. He has also directed global COVID-19 research efforts and the creation of a biorepository for COVID-19 at Rush. Dr. Landay’s wealth of experience and leadership will drive innovation, collaboration, and scientific breakthroughs in UTMB’s Research Enterprise.